227 related articles for article (PubMed ID: 10556145)
1. Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study.
Crowther Labiris NR; Holbrook AM; Chrystyn H; Macleod SM; Newhouse MT
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1711-6. PubMed ID: 10556145
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D
Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
[TBL] [Abstract][Full Text] [Related]
3. Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Parkins MD; Elborn JS
Expert Rev Respir Med; 2011 Oct; 5(5):609-22. PubMed ID: 21955231
[TBL] [Abstract][Full Text] [Related]
4. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
[TBL] [Abstract][Full Text] [Related]
5. Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study.
Stass H; Delesen H; Nagelschmitz J; Staab D
J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):106-15. PubMed ID: 25050456
[TBL] [Abstract][Full Text] [Related]
6. Nebulized gentamicin in combination with systemic antibiotics for eradicating early Pseudomonas aeruginosa infection in children with cystic fibrosis.
Van Stormbroek B; Zampoli M; Morrow BM
Pediatr Pulmonol; 2019 Apr; 54(4):393-398. PubMed ID: 30656856
[TBL] [Abstract][Full Text] [Related]
7. Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study.
Westerman EM; De Boer AH; Le Brun PP; Touw DJ; Roldaan AC; Frijlink HW; Heijerman HG
J Cyst Fibros; 2007 Jul; 6(4):284-92. PubMed ID: 17185047
[TBL] [Abstract][Full Text] [Related]
8. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection].
Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL
Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860
[TBL] [Abstract][Full Text] [Related]
9. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C
Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404
[TBL] [Abstract][Full Text] [Related]
10. Acute respiratory failure due to gentamicin aerosolization.
Melani AS; Di Gregorio A
Monaldi Arch Chest Dis; 1998 Jun; 53(3):274-6. PubMed ID: 9785810
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.
Murray MP; Govan JR; Doherty CJ; Simpson AJ; Wilkinson TS; Chalmers JD; Greening AP; Haslett C; Hill AT
Am J Respir Crit Care Med; 2011 Feb; 183(4):491-9. PubMed ID: 20870753
[TBL] [Abstract][Full Text] [Related]
12. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
13. Quantitative deposition of aerosolized gentamicin in cystic fibrosis.
Ilowite JS; Gorvoy JD; Smaldone GC
Am Rev Respir Dis; 1987 Dec; 136(6):1445-9. PubMed ID: 3688646
[TBL] [Abstract][Full Text] [Related]
14. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.
Tay GT; Reid DW; Bell SC
Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593
[TBL] [Abstract][Full Text] [Related]
15. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
Rubin BK
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):71-6. PubMed ID: 18518833
[TBL] [Abstract][Full Text] [Related]
16. Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine.
Elborn JS; Henig NR
Expert Opin Pharmacother; 2010 Jun; 11(8):1373-85. PubMed ID: 20426707
[TBL] [Abstract][Full Text] [Related]
17. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
Dhand R
J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis.
Hubert D; Leroy S; Nove-Josserand R; Murris-Espin M; Mely L; Dominique S; Delaisi B; Kho P; Kovarik JM
J Cyst Fibros; 2009 Sep; 8(5):332-7. PubMed ID: 19651542
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF
Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Psuedomonas aeruginosa infection.
Bisgaard H; Pedersen SS; Nielsen KG; Skov M; Laursen EM; Kronborg G; Reimert CM; Høiby N; Koch C
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1190-6. PubMed ID: 9351621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
